How does premenstrual dysphoric disorder relate to depression and anxiety disorders?

Depression and Anxiety

Volumn 17, Issue 3, 2003, Pages 122-129

  Landén, Mikael ^a,b,c   Eriksson, Elias ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anxiety; Depression; Panic disorder; Premenstrual dysphoric disorder; Premenstrual syndrome

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

AFFECT; ANXIETY DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; IRRITABILITY; LUTEAL PHASE; MENSTRUATION; META ANALYSIS; PANIC; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; REVIEW; SEROTONINERGIC SYSTEM;

ANXIETY; BRAIN; DEPRESSION; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ESTROGENS; FEMALE; GLUCOCORTICOIDS; HUMANS; LUTEAL PHASE; PREMENSTRUAL SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 0038576157     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.10089     Document Type: Review

References (76)

1. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: APA.
2. Andersch B, Wendestam C, Hahn L, Öhman R. 1986. Premenstrual complaints I. Prevalence of premenstrual symptoms in a Swedish urban population. J Psychosom Obstet Gynaecol 5:39-49.
3. Andersch B. 1983. Bromocriptine and premenstrual symptoms: A survey of double-blind trials. Obstet Gynecol Surv 38:643-646.
4. Angst J, Sellaro R, Merikangas KR, Endicott J. 2001. The epidemiology of premenstrual psychological symptoms. Acta Psychiatr Scand 104:110-116.
5. Bäckström T, Hammarbäck S. 1991. Premenstrual syndrome - psychiatric or gynaecological disorder? Ann Med 23:625-33.
6. Bancroft J, Rennie D, Warner P. 1994. Vulnerability to perimenstrual mood change: The relevance of a past history of depressive disorder. Psychosom Med 56:225-231.
7. Breaux C, Hardage S, Gehlert S. 2000. Relationship of premenstrual dysphoric disorder to major depression and anxiety disorders: A reexamination. J Psychosom Obstet Gynaecol 21:17-24.
8. Cameron OG, Kuttesch D, McPhee K, Curtis GC. 1988. Menstrual fluctuation in the symptoms of panic anxiety. J Affect Disord 15:169-174.
9. Chaturvedi SK, Chandra PS, Gururaj G, Pandian RD, Beena MB. 1995. Suicidal ideas during premenstrual phase. J Affect Disord 34:193-199.
10. Chau JP, Chang AM. 1998. Relationship between premenstrual tension syndrome and anxiety in Chinese adolescents. J Adolesc Health 22:247-249.
11. Cook BL, Noyes R, Jr, Garvey MJ, Beach V, Sobotka J, Chaudhry D. 1990. Anxiety and the menstrual cycle in panic disorder. J Affect Disord 19:221-226.
12. Dimmock PW, Wyatt KM, Jones PW, O'Brien PMS. 2000. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 356:1131-1136.
13. Endicott J, Nee J, Cohen J, Halbreich U. 1986. Premenstrual changes: patterns and correlates of daily ratings. J Affect Disord 10:127-135.
14. Endicott J, Amsterdam J, Eriksson E, Frank E, Freeman E, Hirschfeld R, Ling F, Parry B, Pearlstein T, Rosenbaum J, Rubinow D, Schmidt P, Severino S, Steiner M, Stewart DE, Thys-Jacobs S. 1999. Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med 8:663-679.
15. Eriksson E. 1999. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. Int Clin Psychopharmacol 14 (Suppl 2):S27-33.
16. Eriksson E, Humble M. 1990. Serotonin in psychiatric pathophysiology. A review of data from experimental and clinical research. In: Pohl R, Gershon S, editors. The biological basis of psychiatric treatment. Prog Basic Clin Pharmacol. Basel: Karger. p 66-119.
17. Eriksson E, Lisjö P, Sundblad C, Andersson K, Andersch B, Modigh K. 1990. Effect of clomipramine on premenstrual syndrome. Acta Psychiatr Scand 81:87-88.
18. Eriksson E, Hedberg MA, Andersch B, Sundblad C. 1995. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12:167-176
19. Eriksson E, Sundblad C, Yonkers KA, Steiner M. 2000. Premenstrual dysphoria and related conditions: Symptoms, pathophysiology and treatment. In: Steiner M, Yonkers KA, Eriksson E, editors. Mood disorders in women. London: Martin Dunitz. p 268-293.
20. Facchinetti F, Romano G, Fava M, Genazzani AR. 1992. Lactate infusion induces panic attacks in patients with premenstrual syndrome. Psychosom Med 54:288-296.
21. Frank RT. 1931. Hormonal causes of premenstrual tension. Arch Neurol Psychiatry 26:1053-1057.
22. Freeman EW. 1997. Premenstrual syndrome: Current perspectives on treatment and etiology. Curr Opin Obstet Gynecol 9:147-153.
23. Freeman EW, Rickels K, Schweizer E, Ting T. 1995. Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms. Psychol Med 25:309-315.
24. Freeman EW, Rickels K, Sondheimer SJ, Polansky M. 1999a. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: A randomized controlled trial. Arch Gen Psychiatry. 56:932-939.
25. Freeman EW, Rickels K, Arredondo F, Kao LC, Pollack SE, Sondheimer SJ. 1999b. Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant. J Clin Psychopharmacol 19:3-8.
26. Gloger S, Grunhaus L, Gladic D, O'Ryan F, Cohen L, Codner S. 1989. Panic attacks and agoraphobia: Low-dose clomipramine treatment. J Clin Psychopharmacol 9:28-32.
27. Gorman JM, Kent J, Martinez J, Browne S, Coplan J, Papp LA. 2001. Physiological changes during carbon dioxide inhalation in patients with panic disorder, major depression, and premenstrual dysphoric disorder: evidence for a central fear mechanism. Arch Gen Psychiatry 58:125-131.
28. Halbreich U. 1995. Premenstrual dysphoric disorders, anxiety, and depressions: Vulnerability traits or comorbidity. Arch Gen Psychiatry 52:606.
29. Halbreich U. 1997. Premenstrual dysphoric disorders: A diversified cluster of vulnerability traits to depression. Acta Psychiatr Scand 95:169-176.
30. Halbreich U. 1999. Premenstrual syndromes: Closing the 20th century chapters. Curr Opin Obstet Gynecol 11:265-270.
31. Halbreich U, Endicotr J. 1985. Relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatr Scand 71:331-338.
32. Halbreich U, Smoller JW. 1997. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 58:399-402.
33. Harrison WM, Endicott J, Nee J, Glick H, Rabkin JG. 1989a. Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics 30:405-411.
34. Harrison WM, Sandberg D, Gorman JM, Fyer M, Nee J, Uy J, Endicott J. 1989b. Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. Psychiatry Res 27:183-192.
35. Hardage SA, Arduino KE. 2002. Toward the content validity of premenstrual dysphoric disorder: Do anger and irritability more than depressed mood represent treatment-seekers' experiences? Psychol Rep 90:189-202.
36. Ho HP, Olsson M, Westberg L, Melke J, Eriksson E. 2001. The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: An animal model of premenstrual irritability? Neuropsychopharmacology 24:502-510.
37. Hurt SW, Schnurr PP, Severino SK, Freeman EW, Gise LH, Rivera-Tovar A, Steege JF. 1992. Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am J Psychiatry 149:525-530.
38. Hylan TR, Sundell K, Judge R. 1999. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France. J Womens Health Gend Based Med 8:1043-1052.
39. Jermain DM, Preece CK, Sykes RL, Kuehl TJ, Sulak PJ. 1999. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study. Arch Fam Med 8:328-332.
40. Kendler KS, Silberg JL, Neale MC, Kessler RC, Heath AC, Eaves LJ. 1992. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: A population-based twin study. Psychol Med 22:85-100.
41. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Arch Gen Psychiatry 51:8-19.
42. Klein DF. 1993. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry 50:306-317.
43. Korzekwa MI, Steiner M. 1997. Premenstrual syndromes. Clin Obstet Gynecol 40:564-576.
44. Le Melledo JM, Bradwejn J, Koszycki D, Bichet D. 1995. Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide. Arch Gen Psychiatry 52:605-606.
45. Le Melledo JM, Merani S, Koszycki D, Bellavance F, Palmour R, Gutkowska J, Steinberg S, Bichet DG, Bradwejn J. 1999. Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases. Neuropsychopharmacology 20:81-91.
46. Le Melledo JM, Van Driel M, Coupland NJ, Lott P, Jhangri GS. 2000. Response to flumazenil in women with premenstrual dysphoric disorder. Am J Psychiatry 157:821-823.
47. Magos AL, Brincat M, Studd JW. 1986. Trend analysis of the symptoms of 150 women with a history of the premenstrual syndrome. Am J Obstet Gynecol 155:277-282.
48. Martinez JM, Kent JM, Coplan JD, Browne ST, Papp LA, Sullivan GM, Kleber M, Perepletchikova F, Fyer AJ, Klein DF, Gorman JM. 2001. Respiratory variability in panic disorder. Depress Anxiety 14:232-237.
49. Merikangas KR, Foeldenyi M, Angst J. 1993. The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci 243:23-32.
50. Metcalf MG, Braiden V, Livesey JH. 1992. Symptom cyclicity in women with the premenstrual syndrome: An 8-year follow-up study. J Psychosom Res 36:237-241.
51. Modigh K, Westberg P, Eriksson E. 1992. Superiority of clomipramine over imipramine in the treatment of panic disorder: A placebo-controlled trial. J Clin Psychopharmacol 12:251-261.
52. Morse CA, Dennerstein L, Varnavides K, Burrows GD. 1988. Menstrual cycle symptoms: comparison of a non-clinical sample with a patient group. J Affect Disord 14:41-50.
53. Pearlstein TB, Gillespie JA. 2002. Symptom pattern analysis of PMDD. American Psychiatric Association 2002 Annual Meeting. New Research Abstract 234.
54. Pearlstein T, Stone AB. 1998. Premenstrual syndrome. Psychiatr Clin North 21:577-590.
55. Pearlstein TB, Stone AB, Lund SA, Scheft H, Zlotnick C, Brown WA. 1997. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol 17:261-266.
56. Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA. 2000. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry 61:101-109.
57. Rapkin AJ, Pollack DB, Raleigh MJ, Stone B, McGuire MT. 1995. Menstrual cycle and social behavior in vervet monkeys. Psychoneuroendocrinology 20:289-297.
58. Rubinow DR, Roy-Byrne P, Hoban MC, Gold PW, Post RM. 1984. Prospective assessment of menstrually related mood disorders. Am J Psychiatry 141:684-686.
59. Rubinow DR, Roy-Byrne P, Hoban MC, Grover GN, Stambler N, Post RM. 1986. Premenstrual mood changes. Characteristic patterns in women with and without premenstrual syndrome. J Affect Disord 10:85-90.
60. Sandberg D, Endicott J, Harrison W, Nee J, Gorman J. 1993. Sodium lactate infusion in late luteal phase dysphoric disorder. Psychiatry Res 46:79-88.
61. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. 1998. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338:209-216.
62. Severino SK, Hurt SW, Shindledecker RD. 1989. Spectral analysis of cyclic symptoms in late luteal phase dysphoric disorder. Am J Psychiatry 146:1155-1160.
63. Sigmon ST, Dorhofer DM, Rohan KJ, Hotovy LA, Boulard NE, Fink CM. 2000. Psychophysiological, somatic, and affective changes across the menstrual cycle in women with panic disorder. J Consult Clin Psychol 68:425-431.
64. Stein MB, Schmidt PJ, Rubinow DR, Uhde TW. 1989. Panic disorder and the menstrual cycle: Panic disorder patients, healthy control subjects, and patients with premenstrual syndrome. Am J Psychiatry 146:1299-1303.
65. Steiner M, Born L. 2000. Diagnosis and treatment of premenstrual dysphoric disorder: An update. Int Clin Psychopharmacol 15 (Suppl 3):S5-17.
66. Steiner M, Korzekwa M, Lamont J, Wilkins A. 1997. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol Bull 33:771-774.
67. Stohlman M. 2000. The monthly malady: a history of premenstrual suffering. Medical History 44:301-322.
68. Sundblad C, Modigh K, Andersch B, Eriksson E. 1992. Clomipramine effectively reduces premenstrual irritability and dysphoria: A placebo-controlled trial. Acta Psychiatr Scand 85:39-47.
69. Sundblad C, Hedberg MA, Eriksson E. 1993. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: A placebo-controlled trial. Neuropsycho-pharmacology 9:133-145.
70. Sundström I, Nyberg S, Bäckström T. 1997. Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17:370-381.
71. Wikander I, Sundblad C, Andersch B, Dagnell I, Zylberstein D, Bengtsson F, Eriksson E. 1998. Citalopram in premenstrual dysphoria: Is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 18:390-398.
72. Wittchen HU, Becker E, Lieb R, Krause P. 2002. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 32:119-132.
73. Wood SH, Mortola JF, Chan YF, Moossazadeh F, Yen SS. 1992. Treatment of premenstrual syndrome with fluoxetine: a doubleblind, placebo-controlled, crossover study. Obstet Gynecol 80:339-344.
74. Yonkers K. 1997a. The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry 58 (Suppl 15):19-25.
75. Yonkers KA. 1997b. Anxiety symptoms and anxiety disorders: How are they related to premenstrual disorders? J Clin Psychiatry 58 (Suppl 3):62-67.
76. Young SA, Hurt PH, Benedek DM, Howard RS. 1998. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: A randomized, double-blind, placebo-controlled crossover trial. J Clin Psychiatry 59:76-80.